HTA184 Investigating How Orphan Drug Manufacturers Can Optimize Clinical Trial Design so Patients across Geographies Can Access Life-Saving Innovations
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.1642
https://www.valueinhealthjournal.com/article/S1098-3015(22)03847-5/fulltext
Section Title :
Section Order :
11195
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03847-5&doi=10.1016/j.jval.2022.09.1642